Vanta Bioscience - Board Meeting Intimation for Approval Of Standalone And Consolidated Audited Financial Statements Of The C
16/05/2019 13:53
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2019 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Statements of the Company for the half year and year ended March 31, 2019 and other matters.